Humacyte Global, Inc.
Humacyte is a pioneering regenerative medicine company dedicated to developing bioengineered human tissues and organs that are designed to be universally implantable, off-the-shelf, and regenerative. Their mission is to improve patient outcomes by transforming human cells into regenerative tissues for treating a wide range of diseases, injuries, and chronic conditions. They focus on innovative platforms including Acellular Tissue Engineered Vessels, Advanced Organ Systems, and Advanced Tissue Constructs, with a goal of making tissue repair and replacement accessible to a broader patient population.
Industries
Nr. of Employees
medium (51-250)
Humacyte Global, Inc.
2525 E. Highway NC 54, Durham, NC 27713
Patents
Products
Acellular tissue‑engineered vascular graft (commercial biologic vessel for vascular repair)
A human-derived, decellularized tissue-engineered vascular conduit produced from expanded human vascular cells on biodegradable polymer scaffolds, intended as an off-the-shelf regenerative implant for vascular repair and bypass procedures.
Investigational bioengineered organ and tissue constructs
Preclinical-stage constructs and organ system adaptations of the vascular tissue platform, including vascularized pancreas constructs for Type 1 diabetes, lung constructs, urinary conduits, tracheal and esophageal replacements.
Acellular tissue‑engineered vascular graft (commercial biologic vessel for vascular repair)
A human-derived, decellularized tissue-engineered vascular conduit produced from expanded human vascular cells on biodegradable polymer scaffolds, intended as an off-the-shelf regenerative implant for vascular repair and bypass procedures.
Investigational bioengineered organ and tissue constructs
Preclinical-stage constructs and organ system adaptations of the vascular tissue platform, including vascularized pancreas constructs for Type 1 diabetes, lung constructs, urinary conduits, tracheal and esophageal replacements.
Services
Provision of product-related medical information, clinical education, and peer-to-peer discussion resources for healthcare professionals and investigators.
Assistance for healthcare providers seeking coding and reimbursement information related to product use.
Operational support and clinician training to deploy investigational tissue-engineered vascular products under expanded access programs.
Provision of product-related medical information, clinical education, and peer-to-peer discussion resources for healthcare professionals and investigators.
Assistance for healthcare providers seeking coding and reimbursement information related to product use.
Operational support and clinician training to deploy investigational tissue-engineered vascular products under expanded access programs.
Expertise Areas
- Regenerative medicine and tissue engineering
- Biomanufacturing scale-up for implantable biologics
- Decellularization and extracellular matrix engineering
- Preclinical translational modeling and large-animal studies
Key Technologies
- Acellular tissue-engineered vascular grafts
- Decellularization preserving ECM proteins
- Bioreactor systems with biomechanical conditioning
- Biodegradable polymer mesh scaffolds
News & Updates
VAM25 in New Orleans, LA June 4 - 7 at the New Orleans Convention Center
Visit Booth 320 to learn more about Symvess™ Acellular Tissue Engineered Vessel
VAM25 in New Orleans, LA June 4 - 7 at the New Orleans Convention Center
Visit Booth 320 to learn more about Symvess™ Acellular Tissue Engineered Vessel